Related Experiment Video
Updated: May 16, 2026
10:17
The Tail Suspension Test
Published on: January 28, 2012
[The effect of long-term lithium treatment on kidney function]
Janusz Rybakowski1, Joanna Drogowska, Maria Abramowicz
1Klinika Psychiatrii Dorosłych UM w Poznaniu.
Psychiatria Polska
|December 11, 2012
Summary
Long-term lithium treatment is effective for bipolar disorder but can impair kidney function. Regular kidney monitoring is essential to detect and manage potential lithium-induced nephropathy, ensuring patient safety.
Area of Science:
- Nephrology
- Psychiatry
- Pharmacology
Context:
- Lithium has been the primary mood stabilizer for bipolar disorder since 1963.
- Kidney function significantly influences lithium elimination and efficacy.
- Long-term lithium use is associated with potential renal toxicity.
Purpose:
- To review the nephrotoxic effects of long-term lithium therapy.
- To highlight the importance of renal function monitoring in patients on lithium.
- To discuss management strategies for lithium-induced kidney problems.
Summary:
- Lithium administration can lead to impaired urinary concentrating ability, potentially causing nephrogenic diabetes insipidus.
- Prolonged lithium treatment (10-20 years) may result in interstitial nephropathy, with a risk of end-stage renal disease in some cases.
- Rare complications include lithium-induced hypercalcemia and nephrotic syndrome.
Impact:
- Periodic monitoring of serum creatinine and glomerular filtration rate is crucial for patients on long-term lithium.
- Discontinuation of lithium may be necessary if nephropathy is detected.
- Patients with lithium-induced nephropathy require ongoing nephrological care.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...